Meghmani Organics Ltd - 543331 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Financial Results for Q3 & Nine Months FY2022.02-02-2022
Meghmani Organics Ltd - 543331 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Financial Results for Q3 & Nine Months FY2022.Meghmani Organics Ltd - 543331 - Financial Results (Standalone And Consolidated) For The Third Quarter And Nine Months Ended On December 31, 2021
Outcome of the Board Meeting held on February 2, 2022 and submission of Un-Audited Financial Results (Standalone and Consolidated) for the Third quarter and Nine months ended on December 31, 2021 pursuant to regulation 33 of SEBl (Listing Obligations and Disclosure Requirements), Regulations, 2015Meghmani Organics Ltd - 543331 - Board Meeting Outcome for Outcome Of The Board Meeting.
Outcome of the Board Meeting held on February 2, 2022 and submission of Un-Audited Financial Results (Standalone and Consolidated) for the Third quarter and Nine months ended on December 31, 2021 pursuant to regulation 33 of SEBl (Listing Obligations and Disclosure Requirements), Regulations, 2015.Meghmani Organics Ltd - 543331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Conference call to discuss Q3 & Nine Months FY-2022 EarningsMeghmani Organics Ltd - 543331 - Board Meeting Intimation for Intimation Of Board Meeting For Consideration Of Financial Results For Quarter And Nine Months Ended December 31, 2021.
Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2022 ,inter alia, to consider and approve Pursuant to the requirement of Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 2nd February, 2022, inter alia to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and Nine months ended 31st December, 2021.Meghmani Organics Ltd - 543331 - Delisting Of Singapore Depository Shares From The Singapore Exchange Securities Trading Limited (SGX-ST) With Effect From 17Th January, 2022
The National Company Law Tribunal Bench Ahmedabad, vide its Order dated 03rd May, 2021 has approved the Composite Scheme of Arrangement between Meghmani Organics Limited, Meghmani Organochem Limited and Meghmani Finechem Limited and RESULTANT DELISTING OF SINGAPORE DEPOSITORY SHARES FROM THE SINGAPORE EXCHANGE SECURITIES TRADING LIMITED (SGX-ST). As per the e-mail dated 17th January, 2022 received from Singapore Exchange, Singapore Depository Shares of Meghmani Organics Limited (CIN L24110GJ1995PLC024052) is delisted from the Official List of the Singapore Exchange Securities Trading Limited (SGX-ST) with effect from 9.00 a.m. on 17 January, 2022.Meghmani Organics Ltd - 543331 - Shareholding for the Period Ended December 31, 2021
Meghmani Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click hereMeghmani Organics Ltd - 543331 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate Under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018 for the quarter ended 31.12.2021.Meghmani Organics Ltd - 543331 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Jayesh PatelDesignation :- Company Secretary and Compliance OfficerMeghmani Organics Ltd - 543331 - Closure of Trading Window
Notice of Trading window closure